促销时间表 NeuroSense Therapeutics Ltd.
先进的时间表
简单图表
关于公司
NeuroSense Therapeutics Ltd., a clinical-stage biotechnology company, focuses on discovering and developing treatments for patients suffering from debilitating neurodegenerative diseases in the United States and internationally. Its lead product is PrimeC, an extended-release oral formulation of a fixed dose combination of ciprofloxacin and celecoxib for the treatment of amyotrophic lateral sclerosis. The company's preclinical pipeline includes StabiliC for the treatment of Parkinson's disease; and CogniC for the treatment of Alzheimer's disease. NeuroSense Therapeutics Ltd. 更多详情IPO date | 2021-12-09 |
---|---|
ISIN | IL0011809592 |
Industry | Biotechnology |
Sector | Health Care |
Валюта | usd |
Валюта отчета | usd |
Сайт | https://www.neurosense-tx.com |
Цена ао | 1.7 |
每日价格变化: | +0.7874% (1.27) |
---|---|
每周价格变化: | -5.88% (1.36) |
每月价格变化: | +37.66% (0.9298) |
3个月内价格变化: | 0% (1.28) |
六个月内的价格变化: | +3.23% (1.24) |
每年价格变化: | +63.06% (0.785) |
3年内价格变化: | -61.45% (3.32) |
5年内价格变化: | 0% (1.28) |
10年价格变化: | 0% (1.28) |
年初以来价格变化: | +23.08% (1.04) |
|
低估
|
效率
|
|||||||||||||||||||||||||||||||||||||
股息
|
责任
|
成长冲动
|
机构 | 体积 | 分享, % |
---|---|---|
Armistice Capital, LLC | 662000 | 4.86 |
Meitav Investment House Ltd. | 95000 | 0.7 |
HRT Financial LP | 13998 | 0.1 |
Citadel Advisors Llc | 11702 | 0.09 |
UBS Group AG | 5496 | 0.04 |
CWM, LLC | 1000 | 0.01 |
导师 | 职称 | 支付 | 出生年份 |
---|---|---|---|
Mr. Alon Ben-Noon | Co-Founder, CEO & Director | 619k | 1979 (46 年) |
Mr. Or Eisenberg | Chief Financial Officer | 378k | 1981 (44 年) |
Dr. Ferenc Tracik M.D. | Chief Medical Officer | 513k | 1964 (61 年) |
Ms. Hagit Binder | Chief Operation Officer | N/A | 1978 (47 年) |
Dr. Niva Russek-Blum Ph.D. | Chief Technology Officer | N/A | 1979 (46 年) |
Ms. Yael Barak | VP of Quality & Compliance | N/A | 1970 (55 年) |
Ms. Keren Pushett | Head of HR | N/A | |
Mr. Eidan Loushi | C.R.A. | N/A |